Keep The Facts....Alright guys, Brazilian Population = 209.5 M (2018) Brazil Covid Cases = 4.24 M (sept. 10 google) Population of Sao Paulo 12.18 M (2018) State Sao Paulo = 875,000 cases Sao Pualo % of Brazil Pop = 6.1% Sao Paulo % of Brazil Covid Cases = 20.8% Victory Health CEO is from Brazil -Victory Health approved in the Ideiagov program supported by the Sao Paulo State Government for immediate trials and application in the state to start Aug 28. (Aug 27 news release) -FDA permission to commence marketing, sales and distribution under EUA. (Aug 25, news release) -Announced entering into a manufacturing contract for the IgG and IgM for the detection of Covid 19 rapid tests for sale and distribution globally. -The latest manufacturing agreement will allow the company to produce an ADDITIONAL 5,000,000 VS Health Covid 19 Rapid tests monthly for Global Distribution. (Sept 2 news release) -Victory Health got Brazilian ANVISA approval for Sale and Use of Safetest for the country of Brazil and Export to Mercosur Countries (Argentina, Paraguay, and Uruguay) -This approval increases the companys reach to the entire country of Brazil from prior accelerator approval from State of Sao Paulo release announced in late August. (Sept 8th News Release) -Victory Square Technologies has a $10,000,000 convertible note so money for manufacturing is not an issue here.Market capitalization is currently sitting at $36.5M. Potential sales are roughly $70M a month at $10 per test of which they receive 20%. That is ~$14M a month if all sold in Brazil. They get even more money if the product is sold outside Brazil. $14M a month equates to yearly revenue of $168M. If they have a 30% margin and a P/E ratio of 7 (which I think is low for this space) then $VST will be valued at $352.8M. This is $4.48 a share. Severely undervalued. GLTA Have A Great Weekend. P.s This post was made by a man named Geoff. Ty